Wordt geladen...
Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years
Randomized trials demonstrated the superiority of chemoimmunotherapy over chemotherapy in the frontline treatment of CLL. Based on favorable experience with the addition of mitoxantrone (M) to fludarabine (F) plus cyclophosphamide (C), we designed a pilot study testing the combination of FCM plus ri...
Bewaard in:
| Gepubliceerd in: | Leuk Res |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845644/ https://ncbi.nlm.nih.gov/pubmed/19646755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2009.07.008 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|